Status:

RECRUITING

Impact of Phenylalanine Elevations on Brain and Cognition in Adult PKU Carriers

Lead Sponsor:

University of Missouri-Columbia

Collaborating Sponsors:

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Conditions:

Carrier of Phenylketonuria

Healthy

Eligibility:

All Genders

18-60 years

Phase:

NA

Brief Summary

The goal of this clinical trial is to advance our understanding of the cognitive and neurophysiologic sequelae associated with suboptimal phenylalanine (Phe) metabolism in heterozygous carriers of phe...

Detailed Description

Limitations inherent in past studies of phenylketonuria (PKU) carriers (e.g., poor genetic characterization of sample resulting in inclusion of homozygous non-PKU relatives, reliance on rudimentary or...

Eligibility Criteria

Inclusion

  • Age 18-60 years
  • For the PKU carrier group: Individuals who are the parent of an individual with PKU or who are otherwise have confirmed PKU carrier status (e.g., a sibling of someone with PKU who has had genetic testing done)
  • For the non-carrier group: Individuals who do not have PKU or a family history of PKU

Exclusion

  • Obesity as defined by a body mass index (BMI) over 30\*
  • Taking oral contraceptives on the day of testing session\*
  • Positive cotinine urine test showing nicotine use
  • History of major neurologic condition (e.g., multiple sclerosis, severe closed head injury, Parkinson's disease)) unrelated to PKU and known to adversely impact brain health and function
  • Contraindications for safe MRI participation such as (a) pregnancy or plans to become pregnant during period of study enrollment; or (b) metallic objects inside the body (e.g., surgical staples left in the body following surgery, middle ear prosthesis, metal foreign objects lodged inside the eye, heart pacemakers).

Key Trial Info

Start Date :

January 15 2026

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2026

Estimated Enrollment :

36 Patients enrolled

Trial Details

Trial ID

NCT07220265

Start Date

January 15 2026

End Date

December 31 2026

Last Update

December 23 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Missouri-Columbia

Columbia, Missouri, United States, 65201

Impact of Phenylalanine Elevations on Brain and Cognition in Adult PKU Carriers | DecenTrialz